SecBot SecBot

YARW

Yarrow Bioscience, Inc.
Nasdaq· CIK 0001566044 Biotech & Drug Discovery
$20.00 +0.73 (+3.79%)
Oct 26 4:00 PM ET · prev $19.27
Market cap
$179.3M
Micro cap
Consensus
Buy
89% Buy or better · 9 analysts
Median target
$57.00
+185% · range $56.00–58.00
Next earnings
Nov 4
in 8 days · EPS est. −$0.32
1 year
+13.6%
from $17.60 · Oct 28
30 days
−16.7%
from $24.00
52-week range
$16.40–46.15
−57% from high · low Nov 4
Avg volume 20D
113.1K
shares / day
Short interest
132.0K
≈1.4% of shares · −30.4%
Days to cover
1.3
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
3
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 2 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 4, 2026
Strongest BEARISH Yarrow Bioscience is pricing a $150M follow-on offering of 5,769,231 shares at $26.00/share, a ~10.7%…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • AnalystsBULLISH

    8 of 9 rate it Buy or better. Every target is above the price.

  • Short sellersCOVERING

    Short interest −30.4% to 132.0K shares. 1.3 days to cover, ≈1.4% of shares.

  • TrendDOWNTREND

    27% below its 50-day average.

The Street

9 analysts
Buy 89% rate it Buy or better
Strong Buy3Buy5Hold1Sell0Strong Sell0
12-month targets · 2 analysts

Price is below the lowest target. Median implies +185%.Targets as of Oct 28, 2026.

Recent actions
DateFirmActionRating
Aug 3, 2026BTIG
INITIATE
INITIATEBuy
Jul 28, 2026TD Cowen
INITIATE
INITIATEBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 4, 2026
Earnings date
YARW Q3 2026 Earnings Scheduled — 2026-11-04
Recent
Aug 11, 2026
Listing
Listing Status: YARW — Normal (was Deficient)
Yarrow Bioscience, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N
Jul 28, 2026
Listing
New Listing: YARW — Yarrow Bioscience, Inc. - Common Stock
Listed on exchange Q

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jul 29, 2026
RTW Fund Group GP, LLC
10%+ Owner
OTHER133,290 sh
Jul 29, 2026
RTW Fund Group GP, LLC
10%+ Owner
OTHER133,290 sh
Jul 27, 2026
Zeronda Tyler
Director
AWARD185,798 sh
Jul 27, 2026
Ashiya Mona
Director
AWARD15,435 sh

Earnings setup

Estimates
Nov 4
reports in 8 days
−$0.32
EPS estimate, this quarter
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.32-$0.32–-$0.32—$0.00
Next Q-$0.55-$0.55–-$0.55—$0.00
Current FY-$1.45-$1.45–-$1.45—$0.00
Next FY-$1.65-$1.65–-$1.65—$0.00

Short side

FINRA· Oct 15, 2026
131,992
shares short
-30.4%
vs prior settlement
1.3
days to cover
≈1.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 17, 2026 SEC
Invus Global Management, LLC and affiliated entities filed a Schedule 13G disclosing passive beneficial ownership of…
SC 13G — Impact 3/10
Sep 11, 2026 SEC
Yarrow Bioscience is pricing a $150M follow-on offering of 5,769,231 shares at $26.00/share, a ~10.7% discount to the…
424B5 — Impact 7/10
Aug 20, 2026 SEC
Yarrow Bioscience's shelf registration statement (File No. 333-277609) became effective on August 19, 2026. This…
EFFECT — Impact 5/10
Aug 11, 2026 Listing status
Listing Status: YARW — Normal (was Deficient)
Yarrow Bioscience, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N
Jul 29, 2026 Insider
RTW Fund Group GP, LLC disposed of 133,290 shares
10%+ Owner
Jul 29, 2026 Insider
RTW Fund Group GP, LLC acquired 133,290 shares
10%+ Owner
Jul 27, 2026 Insider
Zeronda Tyler was granted 185,798 shares
Director

SecBot reports

3 filings · 0 bullish · 2 bearish · 1 neutral
All YARW filing & press-release reports (3)